Egyptian Liver Journal

Table 4 Comparison between baseline & post-treatment fasting blood sugar, fasting insulin, HOMA-IR & resistin in naive and relapser group of patients

From: Assessment of serum Resistin in detecting Insulin Resistance and their impact on response to direct acting antiviral in chronic viral hepatitis C patients

			Time		Differences		Paired Test
			Pre	Post	Mean	SD	t	P-value
Naive	FBS (mg/dL)	Mean ±SD	85.350 ± 13.758	76.400 ± 15.551	8.950	6.970	5.743	<0.001*
	Fast Insulin (μU/ml)	Mean ±SD	29.850 ± 7.499	19.150 ± 8.145	10.700	7.263	6.589	<0.001*
	HOMA	Mean ±SD	6.334 ± 2.214	3.645 ± 1.925	2.689	1.477	8.144	<0.001*
	Resistin (ng/L)	Mean ±SD	1715.000 ± 514.807	835.500 ± 668.072	879.500	566.424	6.944	<0.001*
Relapser	FBS (mg/dL)	Mean ±SD	83.800 ± 16.376	74.750 ± 12.422	9.050	8.281	4.887	<0.001*
	Fast Insulin (μU/ml)	Mean ±SD	17.650 ± 5.050	11.250 ± 4.800	6.400	6.992	4.094	<0.001*
	HOMA	Mean ±SD	3.596 ± 1.156	2.012 ± 0.774	1.584	1.495	4.739	<0.001*
	Resistin (ng/L)	Mean ±SD	1735.000 ± 707.869	929.500 ± 619.987	805.500	693.393	5.195	<0.001*

This table shows statistically significant difference between baseline and post-treatment fasting blood sugar, fasting insulin, HOMA-IR, and resistin in naïve and Relapser group of patients being lower post-treatment with p value <0.001*

Back to article page